TDOC
Teladoc HealthBAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Post-earnings news tone is sharply negative, with packet coverage describing a roughly 28% one-day decline and linking the move to therapist shortages and the lowered outlook. Analyst revisions, options, short interest, employee sentiment, and usable social coverage are unavailable. The primary filing provides strong operating evidence, but the high thesis-change score, weak forward visibility, and loose peers support a monitoring-style negative view.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Q2 revenue fell 4% year over year, BetterHelp revenue fell 12%, and BetterHelp adjusted EBITDA margin was only 0.2%. Management said cash-pay pressure accelerated and lowered the BetterHelp outlook [#SEC-8K-2026-07-29]. The sharp post-print decline reduces but does not eliminate further downside risk.
Q3 guidance calls for total revenue of $569-$609 million and BetterHelp revenue growth of negative 24.2% to negative 12.3%, with 0.5%-2.5% adjusted EBITDA margin. The next update will test whether accelerated insurance rollout and provider-capacity actions offset cash-pay weakness [#SEC-8K-2026-07-29].
Integrated Care revenue grew 1% with a 16.5% adjusted EBITDA margin, chronic-care enrollment rose 14%, and Teladoc launched Teladoc One. BetterHelp insurance revenue was near the high end of expectations, but provider capacity limited conversion into sessions and revenue; durable upside requires execution evidence [#SEC-8K-2026-07-29].
Recommendation
No formal recommendation provided.

